缺血性脑血管事件的残余复发风险：概念、分类及意义 - Suppr

Suppr

超能文献

Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications.

作者信息

Wang Yongjun

机构信息

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

China National Clinical Research Center for Neurological Diseases, Beijing, China.

出版信息

Stroke Vasc Neurol. 2021 Jun;6(2):155-157. doi: 10.1136/svn-2021-000885. Epub 2021 Mar 16.

DOI:10.1136/svn-2021-000885

PMID:33727408

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8258047/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb0/8258047/b523dbf005f0/svn-2021-000885f01.jpg

相似文献

Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications.缺血性脑血管事件的残余复发风险：概念、分类及意义

Stroke Vasc Neurol. 2021 Jun;6(2):155-157. doi: 10.1136/svn-2021-000885. Epub 2021 Mar 16.

Night time versus daytime transient ischaemic attack and ischaemic stroke: a prospective study of 110 patients.夜间与白天短暂性脑缺血发作及缺血性脑卒中：110例患者的前瞻性研究

J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):463-7. doi: 10.1136/jnnp.67.4.463.

Early recurrence of cerebrovascular events after transient ischaemic attack.短暂性脑缺血发作后脑血管事件的早期复发

Stroke. 2005 Jan;36(1):1; author reply 1. doi: 10.1161/01.str.0000149929.92356.f1.

Residual Recurrence Risk of Ischemic Cerebrovascular Events: Elements and Implications.缺血性脑血管事件的残余复发风险：要素与影响

Neurosci Bull. 2021 Sep;37(9):1361-1364. doi: 10.1007/s12264-021-00733-5. Epub 2021 Jun 23.

Does inflammation predispose to recurrent vascular events after recent transient ischaemic attack and minor stroke? The North West of England transient ischaemic attack and minor stroke (NORTHSTAR) study.近期短暂性脑缺血发作和小卒中后炎症是否易导致复发性血管事件？英格兰西北部短暂性脑缺血发作和小卒中（NORTHSTAR）研究。

Int J Stroke. 2011 Jun;6(3):187-94. doi: 10.1111/j.1747-4949.2010.00561.x. Epub 2011 Jan 13.

Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study.症状性椎动脉或基底动脉狭窄程度≥50%的发病率及预后：基于人群的前瞻性研究

Brain. 2009 Apr;132(Pt 4):982-8. doi: 10.1093/brain/awp026. Epub 2009 Mar 17.

Differences in the knowledge and compliance with secondary prevention of stroke between transient ischaemic attack patients with and without subsequent stroke.有或无后续卒中的短暂性脑缺血发作患者在卒中二级预防知识及依从性方面的差异。

J Clin Nurs. 2014 Oct;23(19-20):2939-48. doi: 10.1111/jocn.12530. Epub 2014 Jan 21.

Recent advances in management of transient ischaemic attacks and minor ischaemic strokes.短暂性脑缺血发作和轻度缺血性卒中管理的最新进展

Lancet Neurol. 2006 Apr;5(4):323-31. doi: 10.1016/S1474-4422(06)70408-2.

Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack.用于预防缺血性中风或短暂性脑缺血发作后复发的抗凝剂。

Cochrane Database Syst Rev. 2000(2):CD000248. doi: 10.1002/14651858.CD000248.

Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data.近期发生短暂性脑缺血发作或缺血性卒中的高危患者使用氯吡格雷治疗动脉粥样硬化血栓形成（MATCH）：研究设计与基线数据

Cerebrovasc Dis. 2004;17(2-3):253-61. doi: 10.1159/000076962. Epub 2004 Feb 23.

引用本文的文献

Early vascular aging ambulatory score in acute ischemic stroke.急性缺血性卒中的早期血管衰老门诊评分

NPJ Aging. 2025 Feb 21;11(1):13. doi: 10.1038/s41514-025-00202-7.

Risk of major vascular events in patients without traditional risk factors after transient ischemic attack or minor ischemic stroke: An international prospective cohort.短暂性脑缺血发作或轻度缺血性卒中后无传统危险因素患者发生重大血管事件的风险：一项国际前瞻性队列研究

Eur Stroke J. 2024 Nov 21:23969873241300071. doi: 10.1177/23969873241300071.

Functional Outcome Prediction of Acute Ischemic Stroke Based on the Oral and Gut Microbiota.基于口腔和肠道微生物群的急性缺血性中风功能预后预测

Mol Neurobiol. 2025 May;62(5):5413-5431. doi: 10.1007/s12035-024-04618-2. Epub 2024 Nov 15.

Advanced vascular aging and outcomes after acute ischemic stroke: a systematic review and meta-analysis.血管老化与急性缺血性脑卒中结局的相关性：系统评价和荟萃分析。

J Hum Hypertens. 2024 Oct;38(10):676-686. doi: 10.1038/s41371-024-00961-y. Epub 2024 Sep 24.

Association Apo B/Apo a-1 Ratio and Prognostic Nutritional Index with 90-Day Outcomes of Acute Ischemic Stroke.载脂蛋白B/载脂蛋白A-1比值和预后营养指数与急性缺血性卒中90天预后的关系

Diabetes Metab Syndr Obes. 2024 Aug 13;17:3009-3018. doi: 10.2147/DMSO.S473385. eCollection 2024.

Using a k-means clustering to identify novel phenotypes of acute ischemic stroke and development of its Clinlabomics models.使用k均值聚类识别急性缺血性中风的新表型及其临床实验室组学模型的开发。

Front Neurol. 2024 Mar 27;15:1366307. doi: 10.3389/fneur.2024.1366307. eCollection 2024.

High-Sensitivity C-reactive Protein and Intracranial Arterial Stenosis Predicted Recurrent Stroke and Dependence or Death in Minor Stroke or Transient Ischemic Attack.高敏C反应蛋白与颅内动脉狭窄预测小卒中或短暂性脑缺血发作后的复发性卒中、依赖或死亡

J Atheroscler Thromb. 2024 Mar 1;31(3):249-258. doi: 10.5551/jat.64229. Epub 2023 Sep 12.

Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke.hs-CRP 溶栓前预测急性缺血性脑卒中静脉溶栓的安全性及有效性。

BMC Neurol. 2023 Jun 23;23(1):244. doi: 10.1186/s12883-023-03291-7.

Triglyceride-glucose index, symptomatic intracranial artery stenosis and recurrence risk in minor stroke patients with hypertension.甘油三酯-葡萄糖指数、有症状性颅内动脉狭窄与高血压性轻型卒中患者的复发风险

Cardiovasc Diabetol. 2023 Apr 19;22(1):90. doi: 10.1186/s12933-023-01823-6.

High-Sensitivity C-Reactive Protein Modifies P-Wave Terminal Force in Lead V1-Associated Prognosis in Acute Ischemic Stroke or TIA Patients.高敏C反应蛋白改变急性缺血性卒中或短暂性脑缺血发作患者V1导联P波终末电势相关的预后

J Clin Med. 2023 Mar 3;12(5):2031. doi: 10.3390/jcm12052031.

本文引用的文献

Colchicine in Patients with Chronic Coronary Disease.秋水仙碱治疗慢性冠心病

N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke.多组学在脑卒中生物标志物和治疗靶点发现中的应用。

Nat Rev Neurol. 2020 May;16(5):247-264. doi: 10.1038/s41582-020-0350-6. Epub 2020 Apr 22.

Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.同型半胱氨酸水平预测女性小卒中或短暂性脑缺血发作患者对双联抗血小板治疗的反应：CHANCE 试验的亚组分析。

Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):839-846. doi: 10.1161/ATVBAHA.119.313741. Epub 2020 Jan 16.

Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China: A Randomized Clinical Trial.多方面质量改进干预对中国急性缺血性脑卒中患者医院人员执行绩效指标的影响：一项随机临床试验。

JAMA. 2018 Jul 17;320(3):245-254. doi: 10.1001/jama.2018.8802.

Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine.精准医学时代应对残余动脉粥样硬化性心血管疾病风险的概念框架。

Circulation. 2018 Jun 12;137(24):2551-2553. doi: 10.1161/CIRCULATIONAHA.118.035289. Epub 2018 Apr 11.

High-sensitive C-reactive protein and dual antiplatelet in intracranial arterial stenosis.高敏 C 反应蛋白与颅内动脉狭窄的双联抗血小板治疗

Neurology. 2018 Feb 6;90(6):e447-e454. doi: 10.1212/WNL.0000000000004928. Epub 2018 Jan 12.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。

N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.依洛尤单抗与心血管疾病患者的临床结局。

N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.

Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.CYP2C19 失活等位基因状态与氯吡格雷降低小卒中或短暂性脑缺血发作患者风险的疗效之间的关系。

JAMA. 2016 Jul 5;316(1):70-8. doi: 10.1001/jama.2016.8662.

High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome: Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial.高敏C反应蛋白可预测复发性卒中及不良功能预后：急性非致残性脑血管事件高危患者氯吡格雷治疗试验的亚组分析

Stroke. 2016 Aug;47(8):2025-30. doi: 10.1161/STROKEAHA.116.012901. Epub 2016 Jun 21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验